Prairiewood Capital, LLC Abb Vie Inc. Transaction History

Prairiewood Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 20, 2022	SELL	$131.98 - $163.75 $548,376 - $680,381	-4,155 Closed	0 $0
Q4 2021 Jan 20, 2022	SELL	$107.43 - $135.93 $2,685 - $3,398	-25 Reduced 0.6%	4,155 $563,000
Q1 2021 Apr 13, 2021	SELL	$102.3 - $112.62 $428,227 - $471,427	-4,186 Reduced 50.04%	4,180 $452,000
Q4 2020 Jan 15, 2021	BUY	$80.49 - $108.67 $673,379 - $909,133	8,366 New	8,366 $896,000

3,652

1.24B

15.5M

11.6M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $293B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Prairiewood Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Prairiewood Capital, LLC with notifications on news.